Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Gardado en:

Detalles Bibliográficos
Publicado en:	Journal for Immunotherapy of Cancer vol. 13, no. 2 (Feb 2025), p. e009352
Autor Principal:	Eigentler, Thomas
Outros autores:	Thomas, Ioannis, Samoylenko, Igor, Erdmann, Michael, Heinzerling, Lucie, Ochsenreither, Sebastian, Krauss, Jürgen, Oberoi, Arjun, Robert, Caroline, Lebbe, Celeste, Martin-Liberal, Juan, Koch, Lukas, Richtig, Erika, Terheyden, Patrick, Weishaupt, Carsten, Mohr, Peter, Semiletova, Yulia, Casilda Llacer Perez, Brossart, Peter, Bauernfeind, Franz Georg, Fluck, Michael, Poltoratskiy, Artem, Sekacheva, Marina, Soria, Ainara, Schmitt-Bormann, Beate, Gonzalez, Marina, Heß, Jana, Wengenmayer, Peter, Seibel, Tobias, Koch, Sven D, Quintini, Gianluca, Codó, Paula, Falk, Martin, Schönborn-Kellenberger, Oliver, Gnad-Vogt, Ulrike
Publicado:	BMJ Publishing Group LTD
Materias:	Head & neck cancer Biomarkers Squamous cell carcinoma Vaccines Cell death Metastasis Melanoma Peptides Tumors Cancer therapies Immunology Proteins Skin cancer
Acceso en liña:	Citation/Abstract Full Text + Graphics Full Text - PDF
Etiquetas:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Sexa o primeiro en deixar un comentario!